Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Npj Mental Health Research
|
April 12, 2024
Managing expectations with psychedelic microdosing
Omer A Syed, Benjamin Tsang
Neuroscience and Biobehavioral Reviews
|
May 10, 2025
The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field
Omer A Syed, Rotem Petranker, Benjamin Tsang
Neuroscience and Biobehavioral Reviews
|
September 9, 2023
The zebrafish for preclinical psilocybin research
Omer A Syed, Benjamin Tsang, Robert Gerlai
Trends in Pharmacological Sciences
|
September 2, 2023
A perspective on psychedelic teratogenicity: the utility of zebrafish models
Omer A Syed, Benjamin Tsang, Rotem Petranker, et al.
Psychiatry Research
|
January 4, 2026
Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase)
Omer A Syed, Sean M Nestor, Muhammad Ishrat Husain, et al.
Neuroscience and Biobehavioral Reviews
|
January 26, 2026
Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis
Omer A Syed, Benjamin Tsang, Sean M Nestor, et al.
CNS Drugs
|
May 16, 2026
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review
Omer A Syed, Valentyn Sobolenko, Sean M Nestor, et al.
Journal of Psychoactive Drugs
|
November 6, 2024
Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use
Omer A Syed, Rotem Petranker, Emily C Fewster, et al.
Journal of Psychoactive Drugs
|
December 24, 2024
Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey
Omer A Syed, Rotem Petranker, Emily C Fewster, et al.
Bjpsych Open
|
May 13, 2026
Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM
Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Npj Mental Health Research
|
April 12, 2024
Managing expectations with psychedelic microdosing
Omer A Syed, Benjamin Tsang
Neuroscience and Biobehavioral Reviews
|
May 10, 2025
The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field
Omer A Syed, Rotem Petranker, Benjamin Tsang
Neuroscience and Biobehavioral Reviews
|
September 9, 2023
The zebrafish for preclinical psilocybin research
Omer A Syed, Benjamin Tsang, Robert Gerlai
Trends in Pharmacological Sciences
|
September 2, 2023
A perspective on psychedelic teratogenicity: the utility of zebrafish models
Omer A Syed, Benjamin Tsang, Rotem Petranker, et al.
Psychiatry Research
|
January 4, 2026
Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase)
Omer A Syed, Sean M Nestor, Muhammad Ishrat Husain, et al.
Neuroscience and Biobehavioral Reviews
|
January 26, 2026
Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis
Omer A Syed, Benjamin Tsang, Sean M Nestor, et al.
CNS Drugs
|
May 16, 2026
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review
Omer A Syed, Valentyn Sobolenko, Sean M Nestor, et al.
Journal of Psychoactive Drugs
|
November 6, 2024
Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use
Omer A Syed, Rotem Petranker, Emily C Fewster, et al.
Journal of Psychoactive Drugs
|
December 24, 2024
Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey
Omer A Syed, Rotem Petranker, Emily C Fewster, et al.
Bjpsych Open
|
May 13, 2026
Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM
Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, et al.
Page
of 2